SEARCH

SEARCH BY CITATION

References

  • Abel LC, Rizzo LV, Ianni B et al. (2001) Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection. Journal of Autoimmunity 17, 99107.
  • Abel LC, Iwai LK, Viviani W et al. (2005) T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein. Microbes and Infection 7, 11841195.
  • Andrade V, Barral-Neto M & Andrade SG (1985) Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain. Brazilian Journal of Medical and Biological Research 18, 499506.
  • Añez N, Carrasco H, Parada H et al. (1999) Myocardial parasite persistence in chronic chagasic patients. The American Journal of Tropical Medicine and Hygiene 60, 726732.
  • Bahia-Oliveira LMG, Gomes JAS, Rocha MOC et al. (1998) IFN-γ in human Chagas’ disease: protection or pathology? Brazilian Journal of Medical and Biological Research 31, 127131.
  • Basquiera AL, Capra R, Omelianiuka M et al. (2003) Serum Troponin T in Patients With Chronic Chagas Disease. Revista Española de Cardiología 56, 742744.
  • Bestetti RB, Dalbo CM, Freitas OC et al. (1994) Noninvasive predictors of mortality for patients with Chagas’ heart disease: a multivariate stepwise logistic regression study. Cardiology 84, 261267.
  • Brasil, Ministério da Saúde (2005) Consenso Brasileiro em Doença de Chagas. Revista da Sociedade Brasileira de Medicina Tropical 30, 1214.
  • Briere F, Servet-Delprat C, Bridon JM et al. (1994) Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. Journal of Experimental Medicine 179, 757762.
  • Brisinda D, Sorbo AR, Venuti A et al. (2012) Anti-β-adrenoceptors autoimmunity causing ‘idiopathic’ arrhythmias and cardiomyopathy. Circulation Journal 76, 13451353.
  • Carrasco HA, Parada H, Guerrero L et al. (1994) Prognostic implications of clinical electrocardiographic and hemodynamic findings in chronic Chagas disease. The International Journal of Cardiology 43, 2738.
  • Cerban FM, Gea S, Menso E et al. (1993) Chagas’ disease: IgG subclasses against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clinical Immunology and Immunopathology 67, 2530.
  • Chagas C & Villela E (1922) Forma cardíaca da tripanossomíase americana. Memórias do Instituto Oswaldo Cruz 14, 561.
  • Cordeiro FD, Martins-Filho OA, Rocha MOC et al. (2001) Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of humam Chagas’ disease. Clinical and Diagnostic Laboratory Immunology 8, 112118.
  • Cossio PM, Diez D, Szarfman A et al. (1974) Chagasic cardiophaty: demonstration of a serum gamma globin factor which reacts with endocardium and vascular structures. Circulation 49, 1321.
  • Cunha-Neto E, Duranti M, Gruber A et al. (1995) Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proceedings of the National Academy of Sciences USA 92, 35413545.
  • Cunha-Neto E, Coelho V, Guilherme L et al. (1996) Autoimmunity in Chagas’ disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas’ cardiomyopathy patient. The Journal of Clinical Investigation 98, 17091712.
  • D’Ávila D, Guedes PMM, Castro AM et al. (2009) Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Memórias do Instituto Oswaldo Cruz 104, 100105.
  • Gironès N, Rodríguez CI, Carrasco-Marín E et al. (2001) Dominant T- and B-cell epitopes in an autoantigen linked to Chagas’ disease. The Journal of Clinical Investigation 107, 985993.
  • Gomes JA, Bahia-Oliveira LM, Rocha MO et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas’ disease is due to a Th1-specific immune response. Infection and Immunity 71, 11851193.
  • Hernández-Becerril N, Nava A, Reyes PA et al. (2001) IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Archivos de Cardiologia de Mexico 71, 199205.
  • Higuchi ML, De Brito T, Reis MM et al. (1993) Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovascular Pathology 2, 101105.
  • Iwai LK, Juliano MA, Juliano L et al. (2005) T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. Journal of Autoimmunity 24, 111117.
  • Jahns R, Boivin V, Schwarzbach V et al. (2008) Pathological autoantibodies in cardiomyopathy. Autoimmunity 41, 454461.
  • Jones ME, Colley DE, Tostes S et al. (1993) Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesion in human chagasic cardiomyopathy. The American Journal of Tropical Medicine and Hygiene 48, 348357.
  • Kawano Y, Noma T & Yata J (1994) Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. Journal of Immunology 153, 49484958.
  • Kaya Z, Katus HA & Rose NR (2010) Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and heart failure. Clinical Immunology 134, 8088.
  • Kierszenbaum F (1986) Autoimmunity in Chagas’ disease. The Journal of Parasitology 72, 201211.
  • Lages-Silva E, Crema E, Ramirez LE et al. (2001) Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. American Journal of Tropical Medicine and Hygiene 65, 435441.
  • Lang RM, Bierig M, Devereux RB et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography. 18, 14401463.
  • Lappé JM, Pelfrey CM, Cotleur A & Tang WH (2011) Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy. Clinical and Translational Science 4, 317322.
  • Laranja FS, Dias E, Nóbrega G et al. (1956) Chagas's disease: a clinical epidemiologic and pathologic study. Circulation 14, 10351059.
  • Leon JS, Godsel LM, Wang K et al. (2001) Cardiac myosin autoimmunity in acute Chagas heart disease. Infection and Immunity 69, 56435649.
  • Lowry OH, Rosebrough NJ, Farr L et al. (1951) Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193, 265275.
  • Mady C, Cardoso RHA, Barretto ACP et al. (1994) Survival and predictors of survival in patients with congestive heart failure due to Chagas's cardiomyopathy. Circulation 90, 30983102.
  • Monteón-Padilla VM, Hernández-Becerril N, Guzmán-Bracho C et al. (1999) American trypanosomiasis (Chagas’ disease) and blood banking in México city: seroprevalence and its potential transfucional transmission risk. Archives of Medical Research 30, 393398.
  • Monteón-Padilla VM, Hernández-Becerril N, Ballinas-Verdugo MA et al. (2001) Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Archives of Medical Research 32, 3943.
  • Morgan J, Dias JCP, Gontijo ED et al. (1996) Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas’ disease. The American Journal of Tropical Medicine and Hygiene 55, 355359.
  • Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infectious Disease 1, 92100.
  • Reis MM, Higuchi ML, Benvenuti LA et al. (1997) An in situ quantitative immunohistochemical study of cytokines and IL-2R/in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clinical Immunology and Immunopathology 83, 165172.
  • Ribeiro-dos-Santos R & Hudson L (1981) Denervation and the immune response in mice infected with Trypanosoma cruzi. Clinical & Experimental Immunology 44, 349354.
  • Rizzo LV, Cunha-Neto E & Teixeira ARL (1989) Autoimmunity in Chagas’ disease: specific inhibition of reactivity of CD4 +  T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infection and Immunity 57, 26402644.
  • Salvatella R (2007). Achievements in Controlling Chagas Disease in Latin America. World Health Organization, Geneva.
  • Saravia SG, Haberland A, Bartel S et al. (2011) Cardiac troponin T mensured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic chagas disease. Archives of Pathology and Laboratory Medicine 135, 245248.
  • Tibbetts RS, McCormick TS, Rowland EC et al. (1994) Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. The Journal of Immunology 152, 14931499.
  • Umezawa ES & Silveira JF (1999) Serological diagnosis of Chagas disease with purified and defined Trypanosoma cruzi antigens. Memórias do Instituto Oswaldo Cruz 94, 285188.
  • Vago AR, Macedo AM, Adad SJ et al. (1996) PCR detection of Trypanosoma cruzi DNA in esophageal tissues of patients with chronic Chagas’ disease. Lancet 348, 891892.
  • Voller A, Bidwell DE & Bartlett A (1976) Enzyme immunoassays in diagnostic medicine: theory and pratice. Bulletin World Health Organization 53, 5565.
  • World Health Organisation (2010). Chagas Disease: Control and Elimination. Report by the Secretariat. Sixty-third world health assembly. Document A63/17.